137 related articles for article (PubMed ID: 16321391)
1. Adiponectin and inflammatory markers in peripheral arterial occlusive disease.
Iwashima Y; Horio T; Suzuki Y; Kihara S; Rakugi H; Kangawa K; Funahashi T; Ogihara T; Kawano Y
Atherosclerosis; 2006 Oct; 188(2):384-90. PubMed ID: 16321391
[TBL] [Abstract][Full Text] [Related]
2. Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia.
Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Halenka M; Lukes J; Frohlich J
Atherosclerosis; 2008 Apr; 197(2):725-31. PubMed ID: 17714716
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
[TBL] [Abstract][Full Text] [Related]
4. Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation.
Suzuki Y; Horio T; Hayashi T; Nonogi H; Kitamura K; Eto T; Kangawa K; Kawano Y
Regul Pept; 2004 Apr; 118(1-2):99-104. PubMed ID: 14759562
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients.
Masse M; Hébert MJ; Troyanov S; Vigneault N; Sirois I; Madore F
Nephrol Dial Transplant; 2002 Mar; 17(3):485-91. PubMed ID: 11865097
[TBL] [Abstract][Full Text] [Related]
6. Effect of cilostazol treatment on adiponectin and soluble CD40 ligand levels in diabetic patients with peripheral arterial occlusion disease.
Hsieh CJ; Wang PW
Circ J; 2009 May; 73(5):948-54. PubMed ID: 19282610
[TBL] [Abstract][Full Text] [Related]
7. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.
Izquierdo-Porrera AM; Gardner AW; Powell CC; Katzel LI
J Vasc Surg; 2000 Apr; 31(4):670-7. PubMed ID: 10753274
[TBL] [Abstract][Full Text] [Related]
8. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
9. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the presence and extent of peripheral arterial occlusive disease.
Drexel H; Steurer J; Muntwyler J; Meienberg S; Schmid HR; Schneider E; Gröchenig E; Amann FW
Circulation; 1996 Nov; 94(9 Suppl):II199-205. PubMed ID: 8901746
[TBL] [Abstract][Full Text] [Related]
11. Sfrp5/Wnt5a and leptin/adiponectin levels in the serum and the periarterial adipose tissue of patients with peripheral arterial occlusive disease.
Wang B; Pan Y; Yang G; Cui Z; Yu W; Liu H; Bai B
Clin Biochem; 2021 Jan; 87():46-51. PubMed ID: 33188773
[TBL] [Abstract][Full Text] [Related]
12. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
[TBL] [Abstract][Full Text] [Related]
13. Endogenous heparin activity is decreased in peripheral arterial occlusive disease.
Shankar VK; Handa A; Hands L
J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667
[TBL] [Abstract][Full Text] [Related]
14. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
[TBL] [Abstract][Full Text] [Related]
15. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products.
Liu JS; Chuang TJ; Chen JH; Lee CH; Hsieh CH; Lin TK; Hsiao FC; Hung YJ
Endocrine; 2015 Aug; 49(3):703-10. PubMed ID: 25666934
[TBL] [Abstract][Full Text] [Related]
17. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
18. The short-/intermediate-term changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases.
Lee WL; Sheu WH; Liu TJ; Lee WJ; Tsao CR; Ju YH; Liao MF; Chen YT; Ting CT
Atherosclerosis; 2004 Sep; 176(1):125-32. PubMed ID: 15306184
[TBL] [Abstract][Full Text] [Related]
19. Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease.
Wagner HJ; Schmitz R; Alfke H; Klose KJ
Radiology; 2003 Mar; 226(3):791-7. PubMed ID: 12601207
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):593-8. PubMed ID: 11950696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
